Article Details

Kiromic BioPharma C-Suite Execs charged with misleading investors

Retrieved on: 2024-12-05 21:57:23

Tags for this article:

Click the tags to see associated articles and topics

Kiromic BioPharma C-Suite Execs charged with misleading investors. View article details on hiswai:

Excerpt

The Securities and Exchange Commission settled charges against Houston-based Kiromic BioPharma, Inc., and two of its C-Suite executives for ...

Article found on: financialregnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo